- Our Story
- Our Methods
- Quality Improvement
- Health Systems Strengthening
- Social and Behavior Change
- Research and Evaluation
- Global Health Security
- HIV and AIDS
- Maternal, Newborn, and Child Health
- Noncommunicable Diseases
- Reproductive Health and Family Planning
- Vulnerable Children and Families
- Water, Sanitation, and Hygiene
- Our Projects
- Our News
- Join Our Team
Global Health Security
For decades, URC has worked with national programs to advance efforts to combat infectious diseases, including tuberculosis (TB), HIV/AIDS, Zika, Ebola, and other emerging and reemerging diseases, including COVID-19.
URC’s interventions are aligned the Global Health Security Agenda (GHSA), an effort by nations, international organizations, and civil society to accelerate progress toward a world safe and secure from infectious disease threats. GHSA involves addressing infectious disease through the following three approaches:
- Employing an interconnected global network that can respond rapidly and effectively;
- Rapidly detecting and transparently reporting outbreaks when they occur; and
- Preventing and mitigating the impact of naturally occurring outbreaks and intentional or accidental releases of dangerous pathogens.
Research, capacity building, evaluation, and collaboration are key components of all global and bilateral projects implemented by URC. Through these initiatives, we build local capacity in evidence-based policy and programmatic strategy development. Based on our global learning in implementing large and complex projects, URC, as the prime contractor, can provide overall technical and management support to projects.
Under ASSIST, for example, URC established a Research and Evaluation (R&E) Unit, which provided technical support, mentoring, and guidance on country-led research and syntheses of learning across country projects and topics. The R&E Unit used publications to disseminate knowledge to encourage wider adoption, sustainability, and institutionalization of successful approaches and interventions.
URC also has developed strategies and guidelines on disease surveillance and implementing surveillance activities for infectious diseases, bio-security, and bio-safety. For example, working for the Defense Threat Reduction Agency in Vietnam, URC built local capacity in clinical, diagnostic, and laboratory capacity for human and animal disease surveillance essential to meeting international standard between 2017 and 2019.